pirenzepine has been researched along with Esophagitis, Reflux in 3 studies
Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pavlotzky, M | 1 |
| Eshchar, J | 1 |
| Londong, W | 1 |
| Phillips, J | 1 |
| Johnson, NJ | 1 |
| Wood, JR | 1 |
| Niemelä, S | 1 |
| Jääskeläinen, T | 1 |
| Lehtola, J | 1 |
| Martikainen, J | 1 |
| Krekelä, I | 1 |
| Sarna, S | 1 |
| Sarelin, H | 1 |
2 trials available for pirenzepine and Esophagitis, Reflux
| Article | Year |
|---|---|
The effect of combined therapy with ranitidine and pirenzepine in the treatment of reflux oesophagitis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Double-Blind Method; Drug Administration Schedule; Dr | 1992 |
Pirenzepine in the treatment of reflux oesophagitis. A placebo-controlled, double-blind study.
Topics: Adult; Antacids; Clinical Trials as Topic; Double-Blind Method; Esophagitis, Peptic; Female; Gastros | 1986 |
1 other study available for pirenzepine and Esophagitis, Reflux
| Article | Year |
|---|---|
[Pirenzepin--a new drug in peptic diseases].
Topics: Anti-Ulcer Agents; Benzodiazepinones; Esophagitis, Peptic; Humans; Peptic Ulcer; Pirenzepine | 1983 |